El cáncer de mama es el tipo de cáncer más común entre las mujeres en todo el mundo, con 7,8 millones de mujeres diagnosticadas en los últimos cinco años. El riesgo de cáncer de mama aumenta con la edad, la obesidad, el abuso de alcohol, los antecedentes familiares de cáncer de mama, el historial de exposición a la radiación y los antecedentes reproductivos, según la Organización Mundial de la Salud (OMS). El cáncer de mama se cobró la vida de 685.000 personas en todo el mundo en 2020, afectando aproximadamente a 2,3 millones de mujeres y al 0,5%-1% de los hombres. Según las tendencias recientes informadas por el Centro Nacional de Información Biotecnológica, las mujeres indias tienen más probabilidades que las occidentales de desarrollar cáncer de mama a una edad más temprana.
| ATRIBUTO | DETALLES |
| Periodo de estudio | 2020-2029 |
| Año base | 2021 |
| Año estimado | 2022 |
| Año pronosticado | 2022-2029 |
| Periodo histórico | 2018-2020 |
| Unidad | Valor (millones de USD) |
| Segmentación | Por técnica, por uso, por uso final, por región. |
| Por técnica |
|
| Por uso |
|
| Por uso final |
|
| Por región |
|
El aumento de la prevalencia y la concientización sobre el cáncer de mama a través de diversos programas gubernamentales, el avance tecnológico en la ciencia médica y las crecientes aprobaciones gubernamentales para el tratamiento del cáncer son factores clave que impulsan el crecimiento de los ingresos del mercado.
La demanda de dispositivos de localización de lesiones mamarias, que se utilizan para la detección y el mapeo del cáncer de mama, está aumentando. Hasta la fecha, solo unos pocos fabricantes se dedican a la producción de dispositivos de localización de lesiones mamarias. Existe una oportunidad notable para que otros fabricantes pequeños y grandes ingresen al mercado de dispositivos de localización de lesiones mamarias. El cáncer de mama es la enfermedad más común que afecta a las mujeres tanto en los países desarrollados como en los países en desarrollo.
La detección temprana y el mapeo del cáncer de mama pueden ayudar a la capacidad de la patente para curar a los pacientes de manera efectiva con ciertos medicamentos. Como resultado, la detección temprana del cáncer de mama es fundamental para su tratamiento. Además, el gobierno está organizando programas de concienciación sobre el cáncer de mama para aumentar la conciencia pública sobre la enfermedad y eliminar el estigma asociado con los síntomas y el tratamiento del cáncer de mama. Como resultado, estos factores están creando oportunidades para que el mercado de dispositivos de localización de lesiones mamarias crezca durante el período de pronóstico.
Los avances en las técnicas de obtención de imágenes y biopsias, que permiten una detección y localización más precisa y eficiente de las lesiones mamarias, están beneficiando al mercado de los métodos de localización de lesiones mamarias. Según un estudio de Accenture, la tecnología tiene el potencial de generar 150.000 millones de dólares en ahorros anuales para la economía de la salud de Estados Unidos para 2029. Entre estos avances se encuentran las mejoras en las tecnologías de mamografía, ecografía y resonancia magnética, así como el desarrollo de nuevas técnicas como la biopsia estereotáxica y la localización con alambre.
Los avances en la tecnología de imágenes están creando nuevas oportunidades para la detección temprana y el cribado. La tomosíntesis mamaria, también conocida como mamografía tridimensional , es un avance en la tecnología de tratamiento del cáncer. Mediante el uso de imágenes tomadas desde varios ángulos alrededor de la mama, este proceso crea una imagen tridimensional de la misma. Varias empresas líderes están desarrollando nuevos productos de mamografía, que están impulsando el crecimiento de los ingresos del mercado.
The breast lesion localization methods market reached USD 481.66 million in 2021 and is expected to grow at a CAGR of more than 8.9% through 2029, owing to the increasing in awareness about health.
The upcoming trend in the breast lesion localization methods market is an opportunity for market growth.
The global breast lesion localization methods market registered a CAGR of 8.9% from 2022 to 2029.
Key players profiled in the report include Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., Cianna Medical, Surgiceye GmbH and Tsunami S.r.l.
The North America breast lesion localization methods market had largest market share of 36% in 2021. This is primarily due to the high burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer.
In 2021, the wire localization segment dominated the market, accounting for 31% of the total. This segment is driven by factors such as rising prevalence of breast cancer in the population, increasing technologically advanced products, and rising product launches.
The wire localization method is the most commonly used procedure for locating breast lumps or abnormalities. This procedure involves using a fine wire to pinpoint the exact location of the lump or abnormality. The fine-wire or needle localization method is another name for it. According to an article published in the Journal of Personalised Medicine in February 2021, wire localization procedures can be performed using various types of image guidance (mammographic, sonographic, and magnetic resonance imaging).
This is the most commonly used technique for non-palpable breast lesions, with clean margins reported between 70.8% and 87.4% of the time. This type of research is expected to increase its use in treating breast cancer among patients, boosting segment growth.
The global market for breast lesion localization methods is divided into two segments: tumour identification and sentinel lymph node identification. Tumour identification was the largest market in 2021, with a usage revenue of more than USD 553.1 million. The segment for sentinel lymph node identification is further subdivided into lumpectomy and mastectomy.
Over the forecast period, the sentinel lymph node identification segment is expected to grow at a rapid and significant rate. Sentinel lymph node biopsy is becoming more popular for diagnosing breast cancer staging as it is highly sensitive, accurate, and reduces morbidity when compared to conventional methods. Furthermore, combined localization for sentinel lymph node and non-palpable tumours is expected to accelerate segment growth in the future.
The global breast lesion localization methods market is divided into oncology clinics, research institutes, hospitals, and ambulatory surgical centres based on end use. In terms of end user revenue, the hospital segment is expected to generate USD 586.2 million between 2022 and 2029. Rising adoption of advanced breast lesion localization methods to serve an increasing number of breast cancer patients, an increase in the number of hospitals equipped with cutting-edge techniques, and the availability of well-trained professionals are some of the key factors driving segment revenue growth.
[caption id="attachment_23448" align="aligncenter" width="1920"]
The global market is fragmented in nature with the presence of various key players such as Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., Cianna Medical, Surgiceye GmbH and Tsunami S.r.l. along with medium and small-scale regional players operating in different parts of the world. Major companies in the market compete in terms of application development capability, product launches, and development of new technologies for product formulation.
Industry News:Geographically, the Breast Lesion Localization Methods market is segmented into North America, South America, Europe, APAC and MEA.
Asia Pacific is expected to have the highest revenue CAGR of 15.5% during the forecast period. China and India are major revenue contributors to the market in this region. A large breast cancer patient pool, rising healthcare spending and public awareness about breast cancer early detection, and increased investments in breast cancer research are some of the key factors driving market growth. Furthermore, improvements in healthcare infrastructure, government initiatives to promote breast lesion localization procedures, and rising disposable income are all driving revenue growth.
Through the forecast period, the European region is anticipated to experience significant growth at a CAGR of 9.1%. The incidence of breast cancer has increased, and advanced localization techniques are now being used to treat it, which has resulted in a rise in the number of breast cancer patients in European nations. The market for breast lesion localization techniques is expanding as a result of these factors. Consequently, during the forecast period, the European region is anticipated to experience significant growth.
During the forecast period, North America is expected to maintain its dominant position in the global breast lesion localization methods market. The rising prevalence of breast cancer and the availability of cutting-edge services for breast cancer treatment and surgery are two of the primary factors driving market revenue growth in North America. Furthermore, rising awareness about early-stage cancer detection, well-equipped healthcare infrastructures, rapid adoption of advanced breast lesion localization technology, and the presence of key players in the region are some of the other key factors driving North America market growth.
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.